Live WebinarBotiss biomaterials and BLX implants: a smart combination
16 Dec 2019, 06:00 PM Berlin
Dr. Massimo Frosecchi
LISBON, Portugal: This year, Nobel Biocare opened a new chapter for implant dentistry with the launch of new surfaces and the introduction of the new Nobel Biocare N1 implant system. Visitors to the 28th Annual Scientific Meeting of the European Association for Osseointegration (EAO 2019) will have the opportunity tomorrow to view these groundbreaking innovations and discover more about them during an engaging symposium and through interactive hands-on sessions.
NEW YORK, USA: Danaher Corp. has successfully spun off its dental businesses into the company Envista Holdings in a successful public share offering that closed on Sept. 20. With the dental companies Nobel Biocare, Ormco and KaVo Kerr now under its wing, Envista has a unified global portfolio that will allow it to compete with other dental giants Dentsply Sirona and Straumann.
The recent Nobel Biocare Global Symposium saw many of the world’s leading voices on implantology and digital dentistry gather in the Spanish capital of Madrid. At the event, Dental Tribune International spoke with Dr. Pascal Kunz, Vice President of Digital Solutions at Nobel Biocare, about DTX Studio suite and the benefits it provides for both dental clinicians and patients.
MADRID, Spain: Throughout our 60+ years of history, we have consistently stood for genuine innovation, based on science, that was created to help improve the lives of patients around the world. We are dedicated to providing comprehensive training worldwide, and to work together with dental practices and laboratories to help maximise what services and products they offer to their patients. This was on full display at the Nobel Biocare Global Symposium 2019 in Madrid, Spain. We are delighted to announce that the event was a big success. If you were not one of the 1200 participants, take a look at some of the highlights provided in this newsletter.
June 28, 2019 | Advertorial
MADRID, Spain: With the launch of its Xeal abutment surface and TiUltra implant surface this year, Nobel Biocare recently initiated the Mucointegration era for implant dentistry. Now, clinical evidence supporting these pioneering surface innovations for soft-tissue integration has been published in a special supplement of Clinical Implant Dentistry and Related Research (CIDRR).
ZURICH, Suisse : Du 27 au 29 juin, Madrid, la capitale espagnole, accueillera le Symposium mondial Nobel Biocare 2019. Lors de cet événement, les chirurgiens-dentistes pourront découvrir et tester l’avenir de la dentisterie implantaire grâce aux innovations présentées. Parmi celles-ci, le nouveau système Nobel Biocare N1, qui combine la technologie de surface la plus récente de l’entreprise avec une conception biologique qui permet de réduire le temps de traitement et améliorer le confort des patients.
ZURICH, Switzerland: From 27 to 29 June, the Spanish capital of Madrid will play host to the 2019 Nobel Biocare Global Symposium. At this event, dentists will be able to see and experience the future of implant dentistry through the innovations being showcased. Among these will be the new Nobel Biocare N1 system, which combines the company’s latest surface technology with a biologically driven design to reduce treatment time and improve patient comfort.
Dental Tribune International sat down at IDS 2019 with Hans Geiselhöringer, President of Nobel Biocare Systems, to discuss the company’s latest innovations, its upcoming Global Symposium in Madrid, and what he sees as its future focus.